Related Experiment Videos
Recent developments in medical therapy of POAG with beta blocking agents
L M Coulangeon1, C Plane, P Sole
1Service d'Ophtalmologie, C.H.U., Clermont-Ferrand, France.
Bulletin De La Societe Belge D'Ophtalmologie
|January 1, 1992
Summary
Hypertensive patients show papillary pallor changes without visual field alterations. Adrenaline eye drops significantly impact pallor in glaucoma patients, and some hypertensives experience iridic blood barrier breakdown.
Area of Science:
- Ophthalmology
- Cardiovascular Research
Background:
- The CLERTORE project, initiated in 1987, is a comprehensive computerized database tracking ophthalmic data in hypertensive patients.
- This longitudinal study monitors treated and untreated hypertensive individuals through regular, detailed ophthalmic examinations.
Observation:
- Patients undergo bi-annual clinical ophthalmic exams, automated visual field testing (OCTOPUS 500), optic disc analysis (ONHA), and fluorophotometry (FLUOROTRON MASTER).
- Preliminary observations from 92 patients (183 eyes) with up to 42 months follow-up are presented.
Findings:
- Hypertensive patients exhibit papillary pallor modifications unrelated to visual field, C/D ratio, or fluorophotometry changes.
- Adrenaline eye drops demonstrably alter papillary pallor in glaucoma patients.
- A subset of hypertensive patients, both treated and untreated, display evidence of iridic blood barrier disruption.
Implications:
- Papillary pallor may serve as an early indicator of hypertensive ocular changes.
- Further research is warranted to elucidate the mechanisms behind iridic blood barrier breakdown in hypertension.
- The CLERTORE project provides valuable data for understanding the ocular manifestations of systemic hypertension.